Global IVD Leader SSI Diagnostica Group is a global IVD powerhouse formed by three companies with production in San Diego, Virginia, Beijing, and Hillerød and a broad distribution network, presenting a scalable opportunity to cross-sell vaccines testing solutions, culture media, and rapid diagnostic kits to international markets.

Acquisition Growth Recent acquisition of InDevR enhances multiplexed vaccine testing and quality control capabilities, creating a compelling cross-sell for diagnostics, assay development, and QC products to vaccine manufacturers and contract research organizations.

Vaccines / QC Focus Strong involvement in disease prevention and outbreak control with antisera supply and vaccine QC collaboration suggests potential sales for vaccine testing platforms, antisera, and quality control materials across customers in vaccine manufacturing and public health labs.

Certification & Compliance ISO 13485 and MDSAP certifications across sites and ongoing IVDR readiness indicate credibility for FDA-regulated and CE-marked products, making SSI an attractive partner for customers seeking compliant IVD solutions and long-term procurement stability.

SMB to Mid-market Enterprise profile with revenue in the $10–$25 million range and a diverse geographic footprint positions SSI to pursue strategic deals with mid-market healthcare providers, regional distributors, and lab networks seeking scalable IVD kits, media, and rapid tests.